3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Status
Completed
21
Unknown
11
Active not recruiting
8
Terminated
2
Withdrawn
1
Recruiting
1
Not yet recruiting
1
Sponsor Class
INDUSTRY
2
Study Type
Observational
2
Interventional
2
Sponsor
Cancer Type
Breast
2
Conditions
Breast Neoplasms
2
Interventions
Cyclophosphamide
389
Carboplatin
343
Gemcitabine
331
pembrolizumab
328
Cisplatin
327
Paclitaxel
294
Radiotherapy
291
Docetaxel
285
Bevacizumab
249
Rituximab
233
Capecitabine
221
Nivolumab
218
Dexamethasone
205
Fluorouracil
189
fludarabine
177
Oxaliplatin
177
Pemetrexed
153
Doxorubicin
152
Irinotecan
147
Etoposide
144
Leucovorin
143
Cytarabine
133
Bortezomib
129
fludarabine phosphate
128
Cetuximab
126
Lenalidomide
125
Filgrastim
119
Erlotinib Hydrochloride
119
Temozolomide
111
Radiosurgery
110
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Terminated
×
Interventional
×
Mammography
×
Clear all
NCT02324205
2019-02-26
ADAPT
GE Healthcare
Phase NA
Terminated
196 enrolled
9 charts
NCT02540083
2019-02-05
ADAPT-ENRICH
GE Healthcare
Phase NA
Terminated
94 enrolled
9 charts